-
MannKind Provides Business Updates and 2026 Growth Drivers
08 Jan 2026 13:05 GMT
… type 1 or type 2 diabetes with a PDUFA target … serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload … of MannKind Corporation. AFREZZA and MANNKIND are registered trademarks of MannKind Corporation.
MannKind Contacts …
-
Is MannKind Stock a Buy or Sell After the CEO Sold Nearly 66,000 Shares?
25 Dec 2025 03:52 GMT
… Castagna, Chief Executive Officer of MannKind Corporation (NASDAQ:MNKD), executed an … , and patients with diabetes or rare pulmonary conditions.
MannKind Corporation is a … position in the biopharmaceutical sector.
MannKind's innovative approach and …
-
MannKind Shares FUROSCIX® Business Updates
23 Dec 2025 13:05 GMT
… instructions-for-use.pdf). About MannKind
MannKind Corporation (Nasdaq: MNKD) … unmet medical needs, including diabetes, pulmonary hypertension, and fluid … of MannKind Corporation. MANNKIND is a registered trademark of MannKind Corporation.
MannKind Contacts …
-
Cipla launches ‘inhaled insulin’, a needle-free alternative for people with diabetes
22 Dec 2025 16:16 GMT
… its pricing. Afrezza from US’ MannKind Corporation dissolves rapidly upon oral … type-1 and type-2 diabetes mellitus. This differentiated delivery system …
-
Time to Rethink Carb Restriction for Diabetes in Pregnancy
22 Dec 2025 07:02 GMT
… guidance in pregnant individuals with diabetes should be “reframed” with a … or non-insulin-treated preexisting diabetes withdraw from eating carbohydrates until … consulting (without compensation) for Dexcom, MannKind, and Janssen Research & Development …
-
<![CDATA[Diabetes Dialogue: 2026 Technology Updates and American Diabetes Association Standards of Care]]>
17 Dec 2025 18:14 GMT
… disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others … .
References:
American Diabetes Association. The American Diabetes Association …
-
<![CDATA[Diabetes Dialogue: Reacting to Retatrutide and TRIUMPH-4 Topline Data]]>
16 Dec 2025 19:16 GMT
… program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … priorities reflected in the American Diabetes Association’s expanding attention … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …
-
Inhaled Insulin Promising in Youth With Type 1 Diabetes
10 Dec 2025 06:05 GMT
… treatment satisfaction assessed using the Diabetes Treatment Satisfaction Questionnaire change version … and medical device companies including MannKind. One of the authors reported … scientific advisory board member for MannKind, and another reported serving as …
-
Cases of ‘Double Diabetes’ Rising: What to Know
09 Dec 2025 09:20 GMT
… Hirsch, MD, medical director, Diabetes Care Center, University of Washington … with type 2 diabetes, type 1 diabetes has very few approved … patient has type 1 diabetes, type 2 diabetes, or both, if … with Tandem, Dexcom, and Mannkind and a consulting role with …
-
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
01 Dec 2025 13:05 GMT
… instructions-for-use.pdf). About MannKind
MannKind Corporation (Nasdaq: MNKD) … unmet medical needs, including diabetes, pulmonary hypertension, and fluid … of MannKind Corporation. MANNKIND is a registered trademark of MannKind Corporation.
For MannKind: …
About
© 1995-2026